Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

Renalase gene polymorphisms in patients with type 2 diabetes mellitus with and without hypertension

The Egyptian Journal of Internal Medicine volume 25, pages 149–153 (2013)Cite this article

Abstract

Background

Blood pressure (BP) is acutely regulated by the sympathetic nervous system through the action of vasoactive hormones (epinephrine, norepinephrine, and dopamine). Renalase, a recently discovered enzyme with monoamine oxidase activity is implicated in the degradation of catecholamines with a possible role in BP maintenance and cardiac protection against hypertension (HTN) and cardiovascular (CV) events.

Objectives

The aim of this study was to identify the potential involvement of renalase gene polymorphisms in patients with type 2 diabetes mellitus (T2DM) with or without HTN in the absence of diabetic nephropathy and to illustrate the role of renalase gene single-nucleotide polymorphisms (rs2576178 and rs10887800) in CV events.

Study design

This was a cross-sectional study.

Patients and methods

A total of 180 patients with T2DM attending the diabetes and cardiology clinics of Mansoura Hospital were recruited in the study: 100 patients with T2DM with HTN and 80 patients with T2DM who were normotensive. Further, 50 apparently healthy individuals matched in age and sex were included as a reference group. Clinical and laboratory examinations stressing on symptoms and signs of diabetes and HTN complications and ECG and Holter ECG monitoring stressing on QTc and QTd were performed; BMI, lipograms, microalbumin levels, and serum creatinine levels were also determined. Patients with renal disease, hepatic disease, and heart failure, those with previous or present renal or suprarenal lesions or endocrinopathies, and those with secondary HTN were excluded from the study. Genotype determination for two single-nucleotide polymorphisms (rs2576178 and rs10887800) in the renalase gene was carried out using the PCR method.

Results

The frequency of the GG allele of rs2576178 and rs10887800 was insignificantly higher in the diabetic hypertensive group than in the diabetic normotensive group. Both diabetic groups showed higher levels of GG alleles than the control group. The frequency of the GA allele of rs2576178 was significantly higher in the diabetic hypertensive group in comparison with the normotensive diabetic group. The allele frequency of G and A alleles of both studied renalases was also higher in the diabetic hypertensive group in comparison with the diabetic normotensive group; however, the differences were insignificant. The genotype distribution and allele frequencies did not show any statistically significant association with BMI, neuropathy, retinopathy, myocardial ischemia, QTc, or QTd.

Conclusion

The renalase gene can be potentially involved in BP regulation in T2DM. Further large-scale studies on the relationship between renalase and acute coronary syndrome and CV events are warranted.

References

  1. Mazzone T. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention. Am J Med 2007; 120 (Suppl 2): S26–S32.

    Article  CAS  Google Scholar 

  2. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 2000; 85: 251–255.

    Article  CAS  Google Scholar 

  3. Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 2005; 115: 1275–1280.

    Article  CAS  Google Scholar 

  4. Desir GV. Regulation of blood pressure and cardiovascular function by renalase. Kidney Int 2009; 76: 366–370.

    Article  CAS  Google Scholar 

  5. Li G, Xu J, Wang P, Velazquez H, Li Y, Wu Y, et al. Catecholamines regulate the activity, secretion and synthesis of renalase. Circulation 2008; 117: 1277–1282.

    Article  CAS  Google Scholar 

  6. Gu R, Lu W, Xie J, Bai J, Xu B. Renalase deficiency in heart failure model of rats – a potential mechanism underlying circulating norepinephrine accumulation. PLoS One 2011; 6: e14633.

    Article  CAS  Google Scholar 

  7. Wu Y, Xu J, Velazquez H, Wang P, Li G, Liu D, et al. Renalase deficiency aggravates ischemic myocardial damage. Kidney Int 2011; 79: 853–860.

    Article  CAS  Google Scholar 

  8. Zhao Q, Fan Z, He J, Chen S, Li H, Zhang P, et al. Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med 2007; 85: 877–885.

    Article  CAS  Google Scholar 

  9. Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One 2010; 5: 1–b.

    Google Scholar 

  10. Desir GV. Renalase deficiency in chronic kidney disease and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens 2008; 17: 181–185.

    Article  CAS  Google Scholar 

  11. Rampersaud E, Damcott CM, Fu M, Shen H, McArdle P, Shi X, et al. Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the old order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes 2007; 56: 3053–3062.

    Article  CAS  Google Scholar 

  12. Buraczynska M, Zukowski P, Buraczynska K, Mozul S, Ksiazek A. Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Med 2011; 13: 321–327.

    Article  CAS  Google Scholar 

  13. Cowley AW. The genetic dissection of essential hypertension. Nat Rev Genet 2006; 7: 829–840.

    Article  CAS  Google Scholar 

  14. Puddu P, Puddu GM, Cravero E, Ferrari E, Muscari A. The genetic basis of essential hypertension. Acta Cardiol 2007; 62: 281–293.

    Article  Google Scholar 

  15. Adeyemo A, Gerry N, Chen G, Herbert A, Doumatey A, Huang H, et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009; 5: 1000–1564.

    Article  Google Scholar 

  16. Kahn R. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183–1197.

    Article  Google Scholar 

  17. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187.

    Article  CAS  Google Scholar 

  18. Voulgari C, Tentolouris N, Stefanadis C. The ECG vertigo in diabetes and cardiac autonomic neuropathy. Exp Diabetes Res 2011; 2011687624, 17 pages.

  19. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension and cardiovascular disease an update. Hypertension 2001; 37: 1053–1059.

    Article  CAS  Google Scholar 

  20. Wong WT, Wong SL, Tian XY, Huang Y. Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol 2010; 55: 300–307.

    Article  CAS  Google Scholar 

  21. [no authors listed]. 1999 World Health Organization – International Society of Hypertension Guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens 1999; 17: 151–183.

  22. Matarin M, Singleton A, Hardy J, Meschia J. The genetics of ischaemic stroke. J Intern Med 2010; 267: 139–155.

    Article  CAS  Google Scholar 

  23. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis 2000; 36: 646–661.

    Article  CAS  Google Scholar 

  24. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology and Clinical Pathology, Mansoura Faculty of Medicine, 35111, Mansoura, Egypt

    Wael Refaie MD & Ahmad Elewa

Authors
  1. Wael Refaie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmad Elewa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wael Refaie MD.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Refaie, W., Elewa, A. Renalase gene polymorphisms in patients with type 2 diabetes mellitus with and without hypertension. Egypt J Intern Med 25, 149–153 (2013). https://doi.org/10.7123/01.EJIM.0000432881.43500.97

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.7123/01.EJIM.0000432881.43500.97

Keywords